MedPath
HSA Approval

Diflazon Capsule 150mg

SIN13362P

Diflazon Capsule 150mg

Diflazon Capsule 150mg

October 11, 2007

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J02AC01

fluconazole

Manufacturer Information

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

KRKA, d.d., Novo mesto

Active Ingredients

Fluconazole

0.1500 g

Fluconazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diflazon Capsule 150mg - HSA Approval | MedPath